Quick Answer
AC Immune SA reported Total Assets of $154.25 million for fiscal year 2025.
AC Immune SA — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $154.25M -33.2% |
$230.91M +26.3% |
$182.81M -1.7% |
$185.94M -28.9% |
$261.44M +9.5% |
$238.74M -20.2% |
| R&D Expense | $56.44M -9.8% |
$62.57M +14.6% |
$54.61M -9.5% |
$60.34M -3.1% |
$62.28M +4.7% |
$59.49M +18.0% |
- AC Immune SA reported Total Assets of $154.25 million for fiscal year 2025.
- AC Immune SA showed a decrease of -33.2% in Total Assets compared to the prior fiscal year.
- AC Immune SA reported R&D Expense of $56.44 million for fiscal year 2025.
- AC Immune SA showed a decrease of -9.8% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: